Furthermore, to evaluate the role of the expression of these three gene in the prognosis of PCa patients, we used GEPIA to assess the correlation between SCARB1, MAPK3K1, and S100A10 expression and clinical outcomes. The gene discussed is SCARB1; the disease is posterior cortical atrophy.